| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |